SEC Form 4/A · accession 0001461959-17-000003
Q BioMed Inc. · QBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
William S Rosenstadt
Officer — General Counsel · Director · 10% Owner
Period of report
Feb 9, 2017
Accepted (ET)
Mar 30, 2017 · 3:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001596062
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 9, 2017 | S | 3,800 | $4.40 | D | 1,036,200 | D | |
| Common Stock | Feb 10, 2017 | S | 5,000 | $4.38 | D | 1,031,200 | D | |
| Common Stock | Feb 14, 2017 | S | 4,651 | $3.27 | D | 1,026,549 | D | |
| Common Stock | Feb 16, 2017 | S | 1,000 | $4.00 | D | 1,025,549 | D | |
| Common Stock | Feb 17, 2017 | S | 1,800 | $3.86 | D | 1,023,749 | D | |
| Common Stock | Feb 22, 2017 | S | 5,000 | $3.37 | D | 1,018,749 | D | |
| Common Stock | Mar 7, 2017 | S | 900 | $3.73 | D | 1,017,849 | D | |
| Common Stock | Mar 9, 2017 | S | 3,800 | $3.56 | D | 1,014,049 | D | |
| Common Stock | Mar 15, 2017 | S | 1,200 | $3.25 | D | 1,012,849 | D | |
| Common Stock | Mar 16, 2017 | S | 100 | $2.90 | D | 1,012,749 | D | |
| Common Stock | Mar 17, 2017 | S | 1,900 | $3.39 | D | 1,010,849 | D | |
| Common Stock | Mar 21, 2017 | S | 2,200 | $3.40 | D | 1,008,649 | D | |
| Common Stock | Mar 22, 2017 | S | 5,000 | $3.87 | D | 1,003,649 | D | |
| Common Stock | Mar 23, 2017 | S | 5,000 | $4.71 | D | 998,649 | D | |
| Common Stock | Mar 24, 2017 | S | 3,700 | $4.56 | D | 994,949 | D | |
| Common Stock | Mar 27, 2017 | S | 5,000 | $4.72 | D | 989,949 | D | |
| Common Stock | Mar 28, 2017 | S | 5,000 | $5.09 | D | 984,949 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on January 17, 2017 for the sale of up to 92,000 shares of common stock. Such sales were outside of the holder's investment decision.
Remarks
This amendment reflects the proper amount of securities beneficially owned in column 5 of table I.